Search
forResearch 10 of 81
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Cutaneous adverse effects of targeted therapies
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Sorafenib-Associated Facial Acneiform Eruption
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Sorafenib-induced Facial Acneiform Eruption
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →